Skip to content

Investigation of Biomarkers in Susac Syndrome

Investigation of Relevant Biomarkers in Patients With Susac Syndrome

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01273792
Enrollment
30
Registered
2011-01-11
Start date
2010-05-31
Completion date
2021-12-31
Last updated
2021-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Susac Syndrome

Brief summary

Susac Syndrome is a rare disease and the establishment of the diagnosis is often difficult. The aim of this investigation is to identify relevant biomarkers and to elucidate the pathogenesis of Susac syndrome

Detailed description

Susac Syndrome is a rare disease characterized by encephalopathy, branch retinal artery occlusion and sensorineural deafness. The pathogenesis is not yet clear, an autoimmune endotheliopathy is discussed. Because of the variable and often incomplete clinical presentation, the establishment of the diagnosis is often delayed or even completely missed. The aim of this study is to identify biomarkers that facilitate the reliable and prompt establishment of the diagnosis. Patients with a definite diagnosis of Susac syndrome and healthy subjects as controls are investigated. Furthermore, the correlation of serological markers with structural retinal and cerebral changes will contribute to clarification of the pathogenesis of Susac syndrome.

Interventions

None listed

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* adult male and female patients with definite Susac syndrome or matching healthy control subjects * ability to provide informed consent

Exclusion criteria

* pregnancy

Design outcomes

Primary

MeasureTime frameDescription
disease specific patterns of pathology on cranial MRIone-time cranial MRI
disease specific patterns of pathology in optical coherence tomographyone time optical coherence tomography
serological biomarkersnot defined, cross-sectional analysis

Countries

Germany

Contacts

Primary ContactJan M Dörr, MD
jan-markus.doerr@charite.de+49 30 450

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026